EMEA-002264-PIP01-17

Key facts

Active substance
Voclosporin
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0152/2019
PIP number
EMEA-002264-PIP01-17
Pharmaceutical form(s)
Capsule, soft
Condition(s) / indication(s)
Treatment of Systemic Lupus Erythematosus (SLE)
Route(s) of administration
Oral use
Contact for public enquiries
Otsuka Pharmaceutical Netherlands B.V.

E-mail: communications@otsuka-europe.com 
Tel. +44 2037475001

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating
Average
2 ratings